Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
26,131,042
-
Share change
-
+1,735,074
-
Total reported value
-
$288,224,000
-
Price per share
-
$11.03
-
Number of holders
-
72
-
Value change
-
+$21,561,742
-
Number of buys
-
37
-
Number of sells
-
22
Institutional Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q2 2017
As of 30 Jun 2017 AVADEL PHARMACEUTICALS - COM (AVDL) had 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 26,131,042 shares of stock of the company.
Largest 10 holders included Broadfin Capital, LLC, DEERFIELD MANAGEMENT CO, JANUS HENDERSON GROUP PLC, ACADIAN ASSET MANAGEMENT LLC, DEUTSCHE BANK AG\, PERCEPTIVE ADVISORS LLC, ARMISTICE CAPITAL, LLC, BROWN CAPITAL MANAGEMENT LLC, FALCON POINT CAPITAL, LLC, and MILLENNIUM MANAGEMENT LLC.
This table shows 73 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.